50th ASH Annual Meeting and Exposition (December 6 - 9, 2008): Chronic Myeloid Leukemia

Before you can access ASH's online program, you must agree to the following:

Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
For the research and study to be eligible for presentation at the ASH annual meeting, information contained in the abstract, as well as additional data and information to be presented about the research and/or study at the annual meeting, may not be made public before the abstract has been published/presented at the ASH annual meeting.

Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

Chronic Myeloid Leukemia

Saturday, December 6, 2008: 9:30 AM-11:00 AM

Gateway Ballroom - South (Moscone Center)

Saturday, December 6, 2008: 2:00 PM-3:30 PM

Gateway Ballroom - South (Moscone Center)

Milestones and Monitoring in CML Patients Treated with Imatinib

Michael W.N. Deininger, MD

Oregon Health and Science University Cancer Institute, Portland, OR

Novel Agents in CML Therapy: Tyrosine Kinase Inhibitors and Beyond

Junia V. Melo, MD, PhD

Institute of Medical and Veterinary Science, Adelaide, Australia

Catriona Jamieson, MD, PhD

Department of Medicine and Moores Cancer Center, Moores UCSD Cancer Center, La Jolla, CA

See more of: Education Program

<< Previous Session | Next Session >>